African Health Sciences
Makerere University Medical School
Vol. 14, No. 1, 2014, pp. 173-177
Bioline Code: hs14026
Full paper language: English
Document type: Research Article
Document available free of charge
African Health Sciences, Vol. 14, No. 1, 2014, pp. 173-177
© Copyright 2014 - African Health Sciences
In vitro evidence of baicalein’s inhibition of the metabolism of zidovudine (AZT)|
Yu-Cun, Wang; Hai-Yan, Yang; Ling-Ting, Kong & Feng-Xia, Yu
Background: Herb-drug interaction (HDI) has been regarded as a key factor limiting the clinical application of herbs and drugs.
Aims: Potential baicalein-zidovudine (AZT) interaction was predicted in the present study.
Methods: In vitro evaluation of baicalein’s inhibition towards human liver microsomes (HLMs)-catalyzed metabolism of zidovudine (AZT) was performed. Dixon and Lineweaver-Burk plots were used to determine the inhibition kinetic type, and second plot with the slopes from Lineweaver-Burk plot versus the concentrations of baicalein was employed to calculate the inhibition parameter (Ki). In combination with the in vivo concentration of baicalein, in vitro-in vivo extrapolation (IVIVE) was carried out to predict in vivo baicalein-AZT interaction.
Results: Competitive inhibition of baicalein towards AZT metabolism was demonstrated, and the Ki value was calculated to be 101.2 μM. The value of AUCi/AUC was calculated to be 2.
Conclusion: Potential baicalein-AZT interaction was indicated in the present study, indicating the need for monitoring when AZT is co-administrated with baicalein or baicalein-containing herbs.
Baicalein; zidovudine (AZT); metabolism; herb-drug interaction